- Home
- VTYX vs MHH Comparison
VTYX vs MHH Comparison
Compare VTYX & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- MHH
- Stock Information
- Founded
- VTYX 2018
- MHH 1986
- Country
- VTYX United States
- MHH United States
- Employees
- VTYX N/A
- MHH 1397
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- MHH Professional Services
- Sector
- VTYX Health Care
- MHH Consumer Discretionary
- Exchange
- VTYX Nasdaq
- MHH Nasdaq
- Market Cap
- VTYX 154.9M
- MHH 167.4M
- IPO Year
- VTYX 2021
- MHH N/A
- Fundamental
- Price
- VTYX $2.08
- MHH $14.30
- Analyst Decision
- VTYX Buy
- MHH
- Analyst Count
- VTYX 4
- MHH 0
- Target Price
- VTYX $11.33
- MHH N/A
- AVG Volume (30 Days)
- VTYX 1.9M
- MHH 29.9K
- Earning Date
- VTYX 02-25-2025
- MHH 02-05-2025
- Dividend Yield
- VTYX N/A
- MHH N/A
- EPS Growth
- VTYX N/A
- MHH N/A
- EPS
- VTYX N/A
- MHH N/A
- Revenue
- VTYX N/A
- MHH $194,248,000.00
- Revenue This Year
- VTYX N/A
- MHH $0.53
- Revenue Next Year
- VTYX N/A
- MHH $1.53
- P/E Ratio
- VTYX N/A
- MHH N/A
- Revenue Growth
- VTYX N/A
- MHH N/A
- 52 Week Low
- VTYX $1.67
- MHH $7.15
- 52 Week High
- VTYX $11.48
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- VTYX 45.64
- MHH 49.42
- Support Level
- VTYX $1.83
- MHH $13.81
- Resistance Level
- VTYX $2.61
- MHH $15.40
- Average True Range (ATR)
- VTYX 0.18
- MHH 0.92
- MACD
- VTYX -0.03
- MHH -0.08
- Stochastic Oscillator
- VTYX 32.26
- MHH 35.43
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.